About
MyBiotech is a CDMO offering end to end development, manufacturing services and innovative products for biotech and pharma. Involved in multiple national and international projects, MyBiotech focuses on the development, production and characterization of nanopharmaceuticals for diverse administration routes using its proprietary key enabling technologies and GMP-compliant facility in addition to downprocessing of microorganisms.
CL 6: Innovating for sustainable bio-based systems, biotechnology and the bioeconomy
HORIZON-CL6-2026-01-CIRCBIO-07: Advancing the European bio-based innovation enabled by biotechnology and biomanufacturing concepts
CL 6: Innovating for blue bioeconomy and biotechnology value chains
HORIZON-CL6-2026-01-CIRCBIO-11: Harnessing the unique properties of marine organisms to deliver sustainable blue bio-based products
CL4: Sustainable Advanced Materials, Raw Materials and Chemicals
HORIZON-CL4-2027-01-MATERIALS-PRODUCTION-22: Innovative advanced materials and new production processes – reducing dependencies on Critical and Strategic Raw Materials (IA) (Innovative Advanced Materials for the EU and Processes4Planet partnerships)